Silicon Laboratories (NASDAQ:SLAB - Get Free Report) issued an update on its third quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.200-0.400 for the period, compared to the consensus estimate of 0.245. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $203.4 million.
Silicon Laboratories Trading Up 0.9%
Shares of SLAB stock traded up $1.09 during mid-day trading on Friday, reaching $125.42. The stock had a trading volume of 306,566 shares, compared to its average volume of 440,948. The business's fifty day moving average is $138.69 and its 200-day moving average is $128.03. The firm has a market cap of $4.12 billion, a price-to-earnings ratio of -38.95 and a beta of 1.48. Silicon Laboratories has a 1-year low of $82.82 and a 1-year high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million during the quarter, compared to analysts' expectations of $192.57 million. During the same period in the previous year, the business posted ($0.56) EPS. The business's quarterly revenue was up 32.6% compared to the same quarter last year. On average, analysts forecast that Silicon Laboratories will post -0.97 earnings per share for the current year.
Analysts Set New Price Targets
Several brokerages have commented on SLAB. KeyCorp lifted their price objective on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research note on Tuesday, July 8th. Susquehanna boosted their price objective on Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a report on Tuesday, July 22nd. Morgan Stanley decreased their price objective on Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a report on Wednesday. Stifel Nicolaus boosted their price objective on Silicon Laboratories from $144.00 to $160.00 and gave the company a "buy" rating in a report on Friday, July 18th. Finally, Benchmark reissued a "buy" rating and issued a $160.00 price objective on shares of Silicon Laboratories in a report on Tuesday, May 27th. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $151.13.
Check Out Our Latest Analysis on Silicon Laboratories
Insider Transactions at Silicon Laboratories
In related news, CEO Robert Matthew Johnson sold 5,879 shares of the company's stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $771,324.80. Following the completion of the transaction, the chief executive officer owned 73,688 shares of the company's stock, valued at approximately $9,667,865.60. This represents a 7.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Robert J. Conrad sold 4,029 shares of the company's stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $528,604.80. Following the completion of the transaction, the senior vice president directly owned 25,380 shares of the company's stock, valued at $3,329,856. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,080 shares of company stock valued at $1,452,290 in the last ninety days. 1.60% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Silicon Laboratories
A number of large investors have recently bought and sold shares of the business. Millennium Management LLC raised its holdings in Silicon Laboratories by 2,804.1% in the 1st quarter. Millennium Management LLC now owns 99,842 shares of the semiconductor company's stock worth $11,239,000 after purchasing an additional 96,404 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Silicon Laboratories by 1.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 97,156 shares of the semiconductor company's stock worth $10,937,000 after buying an additional 1,679 shares in the last quarter. Jane Street Group LLC increased its stake in Silicon Laboratories by 329.2% during the 1st quarter. Jane Street Group LLC now owns 75,397 shares of the semiconductor company's stock worth $8,487,000 after buying an additional 57,829 shares in the last quarter. AQR Capital Management LLC increased its stake in Silicon Laboratories by 43.7% during the 1st quarter. AQR Capital Management LLC now owns 17,892 shares of the semiconductor company's stock worth $2,001,000 after buying an additional 5,439 shares in the last quarter. Finally, United Services Automobile Association purchased a new stake in Silicon Laboratories during the 1st quarter worth approximately $235,000.
Silicon Laboratories Company Profile
(
Get Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
MarketBeat All Access